![](/img/cover-not-exists.png)
Re: Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms that Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven
Mario A. EisenbergerVolume:
55
Year:
2009
Language:
english
DOI:
10.1016/j.eururo.2008.09.035
File:
PDF, 101 KB
english, 2009